GlobalData on MSN

Kihealth raises $5m to commercialise diabetes assay

Kihealth’s diabetes assay, which measures the earliest biomarker of insulin resistance, is claimed to be the first diagnostic of its kind.

How FDA Approval of Guardant360 CDx as Companion Diagnostic Could Impact Guardant Health (GH) Investors

Guardant Health announced that the FDA has approved its Guardant360 CDx blood test as a companion diagnostic for Eli Lilly’s Inluriyo, enabling the identification of advanced breast cancer patients ...

FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company’s Inluriyo™ (imlunestrant) for Treatment of ESR1-mutated Advanced Breas…

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug ...
Labmate Online

Sixth-generation test transforms emergency heart attack diagnosis

Roche has announced results from the TSIX Study Program, showing that its sixth-generation high-sensitivity Troponin T test ...
Inc

A Study Finds More Fentanyl Showing Up in Workplace Drug Tests. Here’s What to Do About It

Data from New Jersey-based drug test provider Quest Diagnostics involved an analysis of over 8 million workplace drug tests carried out during the last year—meaning the results are statistically ...
Labmate Online

FDA clears new companion diagnostic for KMT2A acute leukaemia

OGT, a global provider of genomic diagnostic and research solutions, has announced that the US Food and Drug Administration ...